CN1179974A - Drug for curing lung cancer - Google Patents
Drug for curing lung cancer Download PDFInfo
- Publication number
- CN1179974A CN1179974A CN 97116962 CN97116962A CN1179974A CN 1179974 A CN1179974 A CN 1179974A CN 97116962 CN97116962 CN 97116962 CN 97116962 A CN97116962 A CN 97116962A CN 1179974 A CN1179974 A CN 1179974A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- lung cancer
- medicine
- baofei
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a new medicine for curing lung cancer "Baofeiwan". It is a Chinese proprietary medicine made up by using Chinese medicine materials adenophora/glehnia root, ophiopogon tuber, coptis root and toad venom and adopting conventional preparation process. Said invented Chinese proprietary medicine possesses the functions of boosting qi and nourishing yin, clearing lung and transforming phlegm, activating blood circulation to dissipate stasis, resolving toxin and dissipating bind, so that it can quickly eliminate cough and phlegm with blood due to lung cancer, and can obviously improve living quality and prolong the life of patient with lung cancer.
Description
The present invention relates to a kind of treatment lung cancer drugs, specifically is the Chinese patent medicine " Baofei bolus " of the treatment pulmonary carcinoma that forms of feedstock production with the prepared slices of Chinese crude drugs.
Pulmonary carcinoma is one of modal malignant tumor, since nearly half a century, the M ﹠ M of many countries and regions pulmonary carcinoma is all rising year by year, in male resident, much more particularly to see, patients with lung cancer often have cough, chest pain, hemoptysis, out of breath, heating, weak, become thin, symptom such as anemia, edema, supraclavicular fossa lymphadenectasis, vertigo can occur late period moves, hepatic metastases, bone transfer etc. can cause death rapidly, bring great misery and financial burden to the patient, serious danger is being assisted human beings'health and existence.
To the treatment of pulmonary carcinoma, modern medicine mainly adopts methods such as operation, radiation and chemotherapy, because primary disease is difficult for finding in early days, most patient has not had surgical condition when making a definite diagnosis, and can only take palliative therapies such as radiotherapy, chemotherapy, though can obtain recent remission rate, can not obviously prolong life cycle.At present, the treatment to pulmonary carcinoma does not have comparatively ideal medicine and therapy as yet.
The object of the present invention is to provide a kind of effects such as beneficial water clearing heat in the lung, the disease of dispelling collateral dredging, purging fire and cooling blood, detoxicating and resolving stagnation of pathogens that have.Can stop symptoms such as the cough that caused by pulmonary carcinoma, bloody sputum rapidly, mitigate the disease alleviates the patient suffering, prolongs the time-to-live, improves the treatment lung cancer drugs of life quality.
Solution of the present invention is based on understanding and the Therapeutic Principle of motherland's medical science to " lump in the right hypochondrium ", by clinical practice for many years, is improved on the basis that guarantor's lung handed down from one's ancestors looses, and improves.At " lump in the right hypochondrium " mainly is because healthy energy is deficient, imbalance of YIN and YANG causes the lungs functional disorder, and mistake department falls in a surname, disorder of QI movement, blood is capable to be obstructed, and makes mental disorder stasis of blood poison glued, with the passing of time forms long-pending this understanding of piece of pulmonary, filter out have supplementing QI and nourishing YIN, 24 kinds of the prepared slices of Chinese crude drugs of lung heat clearing expectorant, blood circulation promoting and blood stasis dispelling, detoxicating and resolving stagnation of pathogens effect, by the theory of Chinese medical science prescription, be processed into pill with conventional method, make the effect of its performance nourishing YIN and clearing away lung-heat, detoxicating and resolving stagnation of pathogens.Medicine of the present invention is made by following component:
Radix Astragali 5g-20g Radix Angelicae Sinensis 5g-20g Radix Adenophorae (Radix Glehniae) 10g-40g 10g-40g Radix Ophiopogonis
Radix Scrophulariae 10g-40g Radix Rehmanniae 10g-40g Bulbus Fritillariae Cirrhosae 10g-20g Sanguis Draxonis 10g-20g
Rhizoma Corydalis 10g-20g Olibanum 10g-20g Myrrha 10g-20g Rhizoma Anemarrhenae 10g-20g
Pollen 10g-30g Fructus Schisandrae Chinensis 10g-20g Rhizoma Dioscoreae 10g-20g Herba Houttuyniae 30g-60g
Rhizoma Coptidis 10g-20g Venenum Bufonis 3g-15g Cinnabaris 10g-20g Herba Portulacae Grandiflorae 20g-40g
The formula optimization weight proportion scope that Sal Nitri 10g-20g Alumen 10g-20g Calculus Bovis 3g-15g Moschus 3g-15g prepares medicine of the present invention is:
Radix Astragali 5g-10g Radix Angelicae Sinensis 5g-10g Radix Adenophorae (Radix Glehniae) 10g-30g 10g-30g Radix Ophiopogonis
Radix Scrophulariae 15g-30g Radix Rehmanniae 15g-30g Bulbus Fritillariae Cirrhosae 10g-15g Sanguis Draxonis 10g-15g
Rhizoma Corydalis 10g-15g Olibanum 10g-15g Myrrha 10g-15g Rhizoma Anemarrhenae 10g-15g
Pollen 15g-20g Fructus Schisandrae Chinensis 10g-15g Rhizoma Dioscoreae 10g-15g Herba Houttuyniae 30g-40g
Rhizoma Coptidis 10g-15g Venenum Bufonis 3g-10g Cinnabaris 10g-15g Herba Portulacae Grandiflorae 20g-30g
The optimum weight proportioning that Sal Nitri 10g-15g Alumen 10g-15g Calculus Bovis 3g-10g Moschus 3g-10g prepares medicine of the present invention is:
Radix Astragali 9g Radix Angelicae Sinensis 9g Radix Adenophorae (Radix Glehniae) 30g 30g Radix Ophiopogonis
Radix Scrophulariae 30g Radix Rehmanniae 30g Bulbus Fritillariae Cirrhosae 10g Sanguis Draxonis 10g
Rhizoma Corydalis 10g Olibanum 10g Myrrha 10g Rhizoma Anemarrhenae 10g
Pollen 15g Fructus Schisandrae Chinensis 10g Rhizoma Dioscoreae 15g Herba Houttuyniae 30g
Rhizoma Coptidis 10g Venenum Bufonis 10g Cinnabaris 10g Herba Portulacae Grandiflorae 20g
Sal Nitri 10g Alumen 10g Calculus Bovis 8g Moschus 8g
With above-mentioned each component medicine according to a conventional method, can make " Baofei bolus " that the present invention treats pulmonary carcinoma.
The present invention is clinical through for many years on the basis of powder handed down from one's ancestors, and constantly perfect improvement forms.Its characteristics are that it is a pure Chinese medicinal preparation, through the clinical use of several generations, determined curative effect.Based on " Baofei bolus ", Comprehensive Treatment pulmonary carcinoma, pulmonary infection etc., clinical symptoms is improved rapidly, exempted the huge infringement that radiotherapy, chemotherapy are brought to patient body, effective percentage can reach more than 90%, is the medicine of a kind of comparatively ideal treatment pulmonary carcinoma, pulmonary infection.
Claims (3)
1. treat lung cancer drugs " Baofei bolus " for one kind, it is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Astragali 5g-20g Radix Angelicae Sinensis 5g-20g Radix Adenophorae (Radix Glehniae) 10g-40g 10g-40g Radix Ophiopogonis
Radix Scrophulariae 10g-40g Radix Rehmanniae 10g-40g Bulbus Fritillariae Cirrhosae 10g-20g Sanguis Draxonis 10g-20g
Rhizoma Corydalis 10g-20g Olibanum 10g-20g Myrrha 10g-20g Rhizoma Anemarrhenae 10g-20g
Pollen 10g-30g Fructus Schisandrae Chinensis 10g-20g Rhizoma Dioscoreae 10g-20g Herba Houttuyniae 30g-60g
Rhizoma Coptidis 10g-20g Venenum Bufonis 3g-15g Cinnabaris 10g-20g Herba Portulacae Grandiflorae 20g-40g
Sal Nitri 10g-20g Alumen 10g-20g Calculus Bovis 3g-15g Moschus 3g-15g
2. according to claim 1 described treatment lung cancer drugs " Baofei bolus ", wherein the mixing ratio by weight of each raw material is:
Radix Astragali 5g-10g Radix Angelicae Sinensis 5g-10g Radix Adenophorae (Radix Glehniae) 10g-30g 10g-30g Radix Ophiopogonis
Radix Scrophulariae 15g-30g Radix Rehmanniae 15g-30g Bulbus Fritillariae Cirrhosae 10g-15g Sanguis Draxonis 10g-15g
Rhizoma Corydalis 10g-15g Olibanum 10g-15g Myrrha 10g-15g Rhizoma Anemarrhenae 10g-15g
Pollen 15g-20g Fructus Schisandrae Chinensis 10g-15g Rhizoma Dioscoreae 10g-15g Herba Houttuyniae 30g-40g
Rhizoma Coptidis 10g-15g Venenum Bufonis 3g-10g Cinnabaris 10g-15g Herba Portulacae Grandiflorae 20g-30g
Sal Nitri 10g-15g Alumen 10g-15g Calculus Bovis 3g-10g Moschus 3g-10g
3. according to claim 1 described treatment lung cancer drugs " Baofei bolus ", wherein the weight proportion of each raw material is:
Radix Astragali 9g Radix Angelicae Sinensis 9g Radix Adenophorae (Radix Glehniae) 30g 30g Radix Ophiopogonis
Radix Scrophulariae 30g Radix Rehmanniae 30g Bulbus Fritillariae Cirrhosae 10g Sanguis Draxonis 10g
Rhizoma Corydalis 10g Olibanum 10g Myrrha 10g Rhizoma Anemarrhenae 10g
Pollen 15g Fructus Schisandrae Chinensis 10g Rhizoma Dioscoreae 15g Herba Houttuyniae 30g
Rhizoma Coptidis 10g Venenum Bufonis 10g Cinnabaris 10g Herba Portulacae Grandiflorae 20g
Sal Nitri 10g Alumen 10g Calculus Bovis 8g Moschus 8g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97116962A CN1058892C (en) | 1997-10-05 | 1997-10-05 | Drug for curing lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97116962A CN1058892C (en) | 1997-10-05 | 1997-10-05 | Drug for curing lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1179974A true CN1179974A (en) | 1998-04-29 |
| CN1058892C CN1058892C (en) | 2000-11-29 |
Family
ID=5174237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97116962A Expired - Fee Related CN1058892C (en) | 1997-10-05 | 1997-10-05 | Drug for curing lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058892C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074295C (en) * | 1999-09-07 | 2001-11-07 | 南中山 | Traditional Chinese medicine Sanfeng anti-cancer capsule for curing lung cancer and preparation process thereof |
| US7569234B2 (en) * | 2003-12-19 | 2009-08-04 | Ming Qi Oncology Chinese Medicines, Inc. | Herb composition for treating lung cancer and preparation method thereof |
| CN101869667B (en) * | 2009-04-21 | 2011-07-27 | 苏尔云 | Chinese herbal medicinal composition for treating lung cancer |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102258676B (en) * | 2010-05-26 | 2013-05-08 | 张蓉 | Composition for preventing lung cancer, and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074613A (en) * | 1993-01-18 | 1993-07-28 | 邱天道 | Xintai paste for heart safety |
| CN1049339C (en) * | 1993-05-10 | 2000-02-16 | 李文升 | Chinese drug tumour removing powder and its preparation |
-
1997
- 1997-10-05 CN CN97116962A patent/CN1058892C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074295C (en) * | 1999-09-07 | 2001-11-07 | 南中山 | Traditional Chinese medicine Sanfeng anti-cancer capsule for curing lung cancer and preparation process thereof |
| US7569234B2 (en) * | 2003-12-19 | 2009-08-04 | Ming Qi Oncology Chinese Medicines, Inc. | Herb composition for treating lung cancer and preparation method thereof |
| CN101869667B (en) * | 2009-04-21 | 2011-07-27 | 苏尔云 | Chinese herbal medicinal composition for treating lung cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1058892C (en) | 2000-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095747A (en) | Chinese traditional medicine for treating various toothache | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN100421717C (en) | A Chinese medicine for treating leukemia | |
| CN1323711C (en) | Chinese medicine for treating liver cancer and carcinoma of pancreas | |
| CN1772256A (en) | Tuberculosis treating Chinese medicine | |
| CN1931329A (en) | Stomatocase treating medicine | |
| CN1058892C (en) | Drug for curing lung cancer | |
| CN1305516C (en) | Chinese medicine for treating chronic hepatitis B | |
| CN101623352A (en) | Medicine for treating acne and preparation method thereof | |
| CN102078517B (en) | Traditional Chinese medicine for treating tumor | |
| CN1049827C (en) | Anti-cancer powder | |
| CN110507772A (en) | A kind of Chinese medicinal ointment and preparation method thereof for treating chronic bronchitis | |
| CN102697984B (en) | Chinese medicinal external application preparation for treating acute mastitis | |
| CN101485827B (en) | Medicament for treating chronic inflammation disease of throat | |
| CN101085247A (en) | Medicine for treating nephritis and uremia and its preparation method | |
| CN1337246A (en) | Chinese medicine for treating cerebral thrombus sequelae | |
| CN1060078C (en) | Chinese herbal medicine composition for curing malignant lymphoma | |
| CN106822733B (en) | Ointment for treating precancerous lesion of chronic atrophic gastritis and preparation method thereof | |
| CN105147994A (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof | |
| CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
| CN103505670A (en) | Traditional Chinese medicine composition for treating primary bronchus lung cancer | |
| CN107596295A (en) | It is a kind of to be used to treat Chinese medicine preparation of lung cancer and preparation method thereof | |
| CN1055235C (en) | Oral liquor for treatment of lung cancer and preparation method therefor | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN101897894A (en) | Traditional Chinese medicine for treating duodenal ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Xiaoheng Document name: Third notice of examination advice |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |